[1] |
Moses RG.Gestational diabetes mellitus:implications of an increased frequency with IADPSG criteria[J].Diabetes Care,2012,35(3):461-462.
|
[2] |
杨冰,王卫淑,裴志强,等.脂蛋白相关磷脂酶A2与2型糖尿病及血管并发症相关性研究[J].中华实用诊断与治疗杂志,2011,25(1):24-27.
|
[3] |
麦彩园,段冬梅,雷琼,等.脂蛋白相关磷脂酶A2与妊娠期糖尿病患者产后糖代谢异常的相关性[J].中华糖尿病杂志,2014,6(9):645-649.
|
[4] |
王文迪,杜鹃.妊娠期糖尿病孕妇脂蛋白相关磷脂酶A2活性的变化及临床意义[J].中国医科大学学报,2014,43 (8):738-739.
|
[5] |
Nelson TL,Kamineni A,Psaty B,et al.Lipoprotein-associated phospholipase A2and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes:the cardiovascular health study[J].Diabetologia,2011,54(2):329-333.
|
[7] |
曹亁,任丽,李晓东.胰岛素抵抗下脂蛋白相关磷脂酶A2介导的炎症因子的表达与动脉硬化关系[J].山西医药杂志,2011,40(3):225-229.
|
[8] |
邢媛,张聪.孕晚期妊娠糖尿病脂联素、瘦素、抵抗素水平与胰岛素抵抗的相关性研究[J].实用临床医药杂志,2014,18(17):76-77.
|
[9] |
金镇,迟鑫姝,滕卫平,等.血糖控制满意的妊娠期糖尿病孕妇血清性激素结合球蛋白水平与妊娠结局的关系[J].中华妇产科杂志,2011,46(6):422-426.
|
[6] |
Noto H,Chitkara P,Raskin P.The role of lipoprotein-associated phospholipase A2in the metabolic syndrome and diabetes[J].J Diab Complications,2006,20(6):343-348.
|
[10] |
周强,陈波,黄海樱,等.抵抗素联合胰岛素抵抗指数在2型糖尿病诊断中的价值[J].中国热带医学,2013,13(6):728-729.
|
[11] |
赖丽萍,陆泽元,李翠吟,等.孕晚期妊娠糖尿病脂联素、瘦素与胰岛素抵抗的相关性[J].实用预防医学,2012,19 (8):1135-1137.
|
[12] |
宋耕,常乐,杨慧霞,等.妊娠糖尿病妇女产后转归的随访性研究[J].中华糖尿病杂志,2012,4(7):208-211.
|
[13] |
Catarino C,Rebelo I,Belo L,et al.Fetal lipoprotein changes in pre-eclampsia[J].Acta Obstet Gynecol Scand,2014,87 (6):628-34.
|
[14] |
Six DA,Derails EA.The expanding superfamily of phospholipase A2enzymes:classification and characterization[J]. Biochim Biophys Acta,2000,1488(1-2):1-19.
|
[15] |
Ankumah NA,Cantu J,Jauk V,et al.Risk of adverse pregnancy outcomes in women with mild chronic hypertension before 20 weeks of gestation[J].Obstet Gynecol,2014,123 (11):966-972.
|
[16] |
詹洪晶.妊娠期糖尿病患者妊娠结局32例临床分析[J].中国现代医生,2013,51(29):131-132.
|